Výsledky vyhledávání

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Publikováno v: Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation, 35(2), 274-282. Oxford University Press
Heerspink, H J L, Stefansson, B, Chertow, G, Correa-Rotter, R, Greene, T, Hou, F F, Lindberg, M, McMurray, J, Rossing, P, Toto, R, Langkilde, A M, Wheeler, D C, Heerspink, H J L, Wheeler, D C, Chertow, G, Correa-Rotter, R, Greene, T, Hou, F F, McMurray, J, Rossing, P, Toto, R, Stefansson, B, Langkilde, A M, Pfeffer, M A, Pocock, S, Swedberg, K, Rouleau, J L, Chaturvedi, N, Ivanovich, P, Levey, A S, Christ-Schmidt, H, Mann, J, Held, C, Varenhorst, C, Holmgren, P, Hallberg, T, Douthat, W, Filho, R P, Cherney, D, Hou, F F, Persson, F, Haller, H, Wittmann, I, Khullar, D, Naoki, K, Correa-Rotter, R, Escudero, E, Isidto, R, Nowicki, M, Batiushin, M & DAPA-CKD Investigators 2020, ' Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial ', Nephrology Dialysis Transplantation, vol. 35, no. 2, pp. 274-282 . https://doi.org/10.1093/ndt/gfz290

Background Recent cardiovascular outcome trials have shown that sodium–glucose co-transporter 2 (SGLT2) inhibitors slow the progression of chronic kidney disease (CKD) in patients with type 2 diabetes at high cardiovascular risk. Whether these bene

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d7ee7be4cfa9b1001a569aca9821c18
https://doi.org/10.1093/ndt/gfz290

Zobrazit plný text záznamu

Periodical

Performance Characteristics of Candidate Criteria for Hemodialysis Arteriovenous Fistula Maturation

Autor: Ng, Jia Hwei, Yang, Wei, Dember, Laura M., Feldman, H., Dember, L., Farber, A., Kaufman, J., Stern, L., LeSage, P., Kivork, C., Soares, D., Malikova, M., Allon, M., Young, C., Taylor, M., Woodard, L., Mangadi, K., Roy-Chaudhury, P., Munda, R., Lee, T., Alloway, R., El-Khatib, M., Canaan, T., Pflum, A., Thieken, L., Campos-Naciff, B., Huber, T., Berceli, S., Jansen, M., McCaslin, G., Trahan, Y., Vazquez, M., Vongpatanasin, W., Davidson, I., Hwang, C., Lightfoot, T., Livingston, C., Valencia, A., Dolmatch, B., Fenves, A., Hawkins, N., Cheung, A., Kraiss, L., Kinikini, D., Treiman, G., Ihnat, D., Sarfati, M., Lavasani, I., Maloney, M., Schlotfeldt, L., Himmelfarb, J., Buchanan, C., Clark, C., Crawford, C., Hamlett, J., Kundzins, J., Manahan, L., Wise, J., Beck, G., Gassman, J., Greene, T., Imrey, P., Li, L., Alster, J., Li, M., MacKrell, J., Radeva, M., Weiss, B., Wiggins, K., Alpers, C., Hudkins, K., Wietecha, T., Robbin, M., Umphrey, H., Alexander, L., Abts, C., Belt, L., Vita, J., Hamburg, N., Duess, M., Levit, A., Higgins, H., Ke, S., Mandaci, O., Snell, C., Gravley, J., Behnken, S., Mortensen, R., Chertow, G., Besarab, A., Brayman, K., Diener-West, M., Harrison, D., Inker, L., Louis, T., McClellan, W., Rubin, J., Kusek, J., Star, R.

Publikováno v: Clinical Journal of The American Society of Nephrology; October 2023, Vol. 18 Issue: 10 p1321-1332, 12p

Zobrazit plný text záznamu

Akademický článek

Implications of a Race Term in GFR Estimates Used to Predict AKI After Coronary Intervention.

Autor: Uzendu A; Cardiovascular Outcomes, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri Kansas City, Kansas City, Missouri, USA. Electronic address: uzendu14@gmail.com., Kennedy K; Cardiovascular Outcomes, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri Kansas City, Kansas City, Missouri, USA., Chertow G; Department of Medicine, Stanford University, Stanford, California, USA., Amin AP; Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA., Giri JS; Penn Center for Quality, Outcomes, and Evaluative Research, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania, USA., Rymer JA; Department of Medicine, Duke University, Durham, North Carolina, USA., Bangalore S; Department of Medicine, New York University Langone, New York, New York, USA., Lavin K; Department of Science and Quality, American College of Cardiology, Washington, DC, USA., Anderson C; Department of Science and Quality, American College of Cardiology, Washington, DC, USA., Spertus JA; Cardiovascular Outcomes, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri Kansas City, Kansas City, Missouri, USA.

Publikováno v: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2023 Sep 25; Vol. 16 (18), pp. 2309-2320.

Zobrazit plný text záznamu

Akademický článek

Contemporary Methods for Predicting Acute Kidney Injury After Coronary Intervention.

Autor: Uzendu A; Cardiovascular Outcomes, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri Kansas City, Kansas City, Missouri, USA. Electronic address: uzendu14@gmail.com., Kennedy K; Cardiovascular Outcomes, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri Kansas City, Kansas City, Missouri, USA., Chertow G; Department of Medicine, Stanford University, Stanford, California, USA., Amin AP; Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA., Giri JS; Penn Center for Quality, Outcomes, and Evaluative Research, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania, USA., Rymer JA; Department of Medicine, Duke University, Durham, North Carolina, USA., Bangalore S; Department of Medicine, New York University Langone, New York, New York, USA., Lavin K; Department of Science and Quality, American College of Cardiology, Washington, DC, USA., Anderson C; Department of Science and Quality, American College of Cardiology, Washington, DC, USA., Wang TY; Department of Medicine, Duke University, Durham, North Carolina, USA., Curtis JP; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Spertus JA; Cardiovascular Outcomes, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri Kansas City, Kansas City, Missouri, USA.

Publikováno v: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2023 Sep 25; Vol. 16 (18), pp. 2294-2305.

Zobrazit plný text záznamu

Akademický článek

Dynamic Remodeling of Human Arteriovenous Fistula Wall Obtained From Magnetic Resonance Imaging During the First 6 Months After Creation

Autor: Feldman, H., Dember, L., Farber, A., Kaufman, J., Stern, L., LeSage, P., Kivork, C., Soares, D., Malikova, M., Allon, M., Young, C., Taylor, M., Woodard, L., Mangadi, K., Roy-Chaudhury, P., Munda, R., Lee, T., Alloway, R., El-Khatib, M., Canaan, T., Pflum, A., Thieken, L., Campos-Naciff, B., Huber, T., Berceli, S., Jansen, M., McCaslin, G., Trahan, Y., Vazquez, M., Vongpatanasin, W., Davidson, I., Hwang, C., Lightfoot, T., Livingston, C., Valencia, A., Dolmatch, B., Fenves, A., Hawkins, N., Cheung, A., Kraiss, L., Kinikini, D., Treiman, G., Ihnat, D., Sarfati, M., Lavasani, I., Maloney, M., Schlotfeldt, L., Himmelfarb, J., Buchanan, C., Clark, C., Crawford, C., Hamlett, J., Kundzins, J., Manahan, L., Wise, J., Beck, G., Gassman, J., Greene, T., Imrey, P., Li, L., Alster, J., Li, M., MacKrell, J., Radeva, M., Weiss, B., Wiggins, K., Alpers, C., Hudkins, K., Wietecha, T., Robbin, M., Umphrey, H., Alexander, L., Abts, C., Belt, L., Vita, J., Hamburg, N., Duess, M., Levit, A., Higgins, H., Ke, S., Mandaci, O., Snell, C., Gravley, J., Behnken, S., Mortensen, R., Chertow, G., Besarab, A., Brayman, K., Diener-West, M., Harrison, D., Inker, L., Louis, T., McClellan, W., Rubin, J., Kusek, J., Star, R., Li, Yingnan, He, Yong, Falzon, Isabelle, Fairbourn, Brayden, Tingey, Spencer, Imrey, Peter B., Radeva, Milena K., Beck, Gerald J., Gassman, Jennifer J., Roy-Chaudhury, Prabir, Berceli, Scott A., Cheung, Alfred K., Shiu, Yan-Ting

Publikováno v: In Kidney International Reports August 2022 7(8):1905-1909

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease

Autor: Chertow G, Vart P, Jongs N, Toto R, Gorriz J, Hou F, McMurray J, Correa-Rotter R, Rossing P, Sjostrom C, Stefansson B, Langkilde A, Wheeler D, Heerspink H, DAPA-CKD Trial Committees and Investigators

Publikováno v: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

BACKGROUND: In the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized, placebo-controlled trial, the sodium-glucose cotransporter 2 inhibitor dapagliflozin significantly reduced risk of kidney failure and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::1846c91c889e5765ecd50b8baf286113
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15969

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání